Brief: Syros Pharmaceuticals Says On July 18, Got Notice From Pfizer, Inc.

Syros Pharmaceuticals

21/07/2023 21:43

July 21 (Reuters) - Pfizer Inc  PFE.N :
    * SYROS PHARMACEUTICALS - ON JULY 18, GOT NOTICE FROM
PFIZER, INC.
    * SYROS PHARMACEUTICALS - GOT NOTICE THAT PFIZER ELECTED TO
EXERCISE ITS RIGHT TO TERMINATE LICENSE AND COLLABORATION
AGREEMENT DATED DECEMBER 17, 2019
    * SYROS PHARMACEUTICALS INC - EFFECTIVE DATE OF TERMINATION
OF
LICENSE AND COLLABORATION AGREEMENT DATED DEC 17, 2019 IS OCT
16, 2023
    * SYROS PHARMACEUTICALS INC - INTENDS TO SEEK TO IDENTIFY A
NEW
OUT-LICENSING PARTNER FOR ITS SICKLE CELL DISEASE PROGRAM
    * SYROS PHARMACEUTICALS - LICENSE AND COLLABORATION
AGREEMENT BY
AND BETWEEN CO AND GLOBAL BLOOD THERAPEUTICS, INC.

Further company coverage:  PFE.N 

 (Reuters.Briefs@thomsonreuters.com)